Back to Conference Homepage
Back to Conference Faculty List
Back to Conference Schedule
Presentation: Breast Cancer Genetics
CLICK HERE to see the PowerPoint presentation
Time: Saturday Morning
Purpose: To educate attendees about genetics in breast cancer and implications for clinical practice, specifically as relates to the care of Patients of Chinese ethnicity
Objectives:
Identify measures available to screen for breast cancer
Review BRCA 1 and BRCA 2 genes, and the situations in which genetic testing is indicated
Review BRCA1/2 mutation epidemiology in Chinese and other populations
Review recommendations for the application of BRCA1/2 testing, and for appropriate genetic counseling in Chinese American populations
Describe ethical and legal issues related to cancer genetics
Review management strategies based on specific genetic testing results
Review emerging developments and research priorities in breast cancer genetics
Assistant Professor of Medicine & Health Research and Policy, Stanford University School of Medicine
Associate Director of the Stanford Program for Clinical Cancer Genetics
Bio:
Allison W. Kurian, M.D., M.Sc. is an Assistant Professor of Medicine and of Health Research and Policy at Stanford University School of Medicine. She received her medical degree from Harvard Medical School, did her residency in Internal Medicine at the Massachusetts General Hospital, and completed her fellowship training in Medical Oncology along with a master’s degree in Epidemiology at Stanford University. As Associate Director of the Stanford Program for Clinical Cancer Genetics, her clinical practice centers on women at high risk for developing breast and ovarian cancer. Her research focuses on identification of women with elevated breast and ovarian cancer risk, and on development and evaluation of novel techniques for early cancer detection and risk reduction; this research is supported by grant funding from the National Institutes of Health, Susan G. Komen Breast Cancer Foundation, American Society of Clinical Oncology, California Breast Cancer Research Program, and Robert Wood Johnson Foundation.